BLLN BillionToOne (BLLN) Q4 FY25 earnings call
BillionToOne delivered exceptional Q4 and full-year 2025 results, demonstrating robust growth and profitability that exceeded expectations, including prior guidance. The company's unique technology platform and differentiated products in prenatal and oncology drove significant increases in test volume and ASPs, while operational efficiencies improved margins. A key highlight was securing an in-network contract with UnitedHealthcare, expected to further accelerate growth and ASPs, positioning the company for a consequential 2026.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
BLLN operating KPIs by quarter
| KPI | This call Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|
| Procedures | ~170KOur leadership in product innovation and our growing commercial team continue to drive our test volume with Q4 reaching approximately 170,000 tests, a 47% year-over-year increase.Source: earnings call transcript | ~188KIn Q1, we delivered approximately 188,000 tests, representing 44% year-over-year growth and strong sequential growth across both product lines, with prenatal volumes growing approximately 10% quarter-over-quarter and oncology volumes growing approximately 25% quarter-over-quarter.Source: earnings call transcript | — | — |
| Average selling price | $561Overall ASP increased another 12% quarter-over-quarter from $501 to $561, a significant $60 per test increase in a single quarter.Source: earnings call transcript | $571As our ASPs increased 28% year-over-year to $571 per test and as we maintained our COGS at $153 per test despite the higher proportion of oncology tests that have a higher COGS, we expanded our gross margins to 73% in Q1, a strong 9 percentage point increase year-over-year.Source: earnings call transcript | $551Overall ASP increased 21% year-over-year to $551 per test.Source: earnings call transcript | -3.5% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.